Insomnia, hypnotic drugs and traffic safety

Drugs, Driving and Traffic Safety

Volumn , Issue , 2009, Pages 233-244

  Verster, Joris C ^a   Mets, Monique A J ^a   Leufkens, Tim R M ^b   Vermeeren, Annemiek ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79951819650     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7643-9923-8_14     Document Type: Chapter

References (27)

1. Ohayon MM (2002) Epidemiology of insomnia: What we know and what we still need to learn. Sleep Med Rev 6:97-111
2. Verster JC, Pandi-Perumal SR, Streiner DL (Eds) (2008) Sleep and Quality of Life in Clinical Medicine. Humana Press (Springer).
3. Morin AK, Jarvis CI, Lynch AM (2007) Therapeutic options for sleep-maintenance and sleep-onset insomnia. Pharmacotherapy 27:89-110
4. Verster JC, Veldhuijzen DS, Patat A, Olivier B, Volkerts ER (2006) Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Current Drug Safety 1:63-72.
5. Vermeeren A (2004) Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 18:1-37
6. O'Hanlon JF (1984) Driving performance under the influence of drugs: rationale for, and application of, a new test. Br J Clin Pharmacol 18:121S-129S.
7. Volkerts ER, Louwerens JW, Gloerich ABM, et al. (1984) Zopiclone's residual effect upon actual driving performance versus those of nitrazepam and flunitrazepam. VSC, Report 84-10, TrafficResearchCentre, Groningen, The Netherlands
8. O'Hanlon JF, Volkerts ER (1986) Hypnotics and actual driving ability. Acta Psychiatr Scand 74(snppl 332):95-104.
9. Brookhuis KA, Volkerts ER, O'Hanlon IF (1990) Repeated dose effects of lormetazepam and flurazepam upon driving performance. Eur J Clin Pharmacol 38:1-5.
10. Volkerts ER, Van Laar MW, Van Willigenburg APP (1992) A comparative study of on-theroad and simulated driving performance after nocturnal treatment with lormetazepam 1 mg and oxazepam 50 mg. Hum Psychopharmacol 7:297-309
11. Louwerens JW, Gloerich ABM, De Vries G, Brookhuis KA, O'Hanlon JF (1987) The relationship between drivers' blood alcohol concentration (BAC) and actual driving performance during high speed travel. In: Noordzij, PC. and Roszbach R. (Eds) Alcohol, Drugs and Traffic Safety. Amsterdam: Excerpta Medica. 183-192.
12. Vermeeren A, Danjou PE, O'Hanlon JF (1998) Residual effects of evening and middle-ofthe-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Hum Psychopharmacol Clin Exp 13, S98-S107
13. Vermeeren A, O'Hanlon JF, De Clerck AC, et al. (1995) Acute effects of Zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo. Acta Therapeutica 21:47-64
14. Bocca ML, Le Doze F, Etard O et al. (1999) Residual effect of Zolpidem 10 mg and zopiclone 7.5 mg versus flunitrazepam 1 mg and placebo on driving performance and ocularsaccades. Psychopharmacology 143:373-379
15. Schmidt U, Brendemuhl D, Ruther E (1986) Aspects of driving after hypnotic therapy with particular reference to temazepam. Acta Psychiatr Scand 332(suppl):112-118
16. Ludice A, Bonnani E, Maestri M et al. (2002) Lormetazepam effects on daytime vigilance, psychomotor performance and simulated driving in young adult healthy volunteers. Int J Clin Pharmacol Ther 40:304-309.
17. Betts TA, Birtle J (1982) Effects of two hypnotics on actual driving performance next morning. Br Med J 285:852.
18. Laurell H, Tornros J (1986) The carry-over effects of triazolam compared with nitrazepam and placebo in acute emergency driving situations and in monotonous simulated driving. Acta Pharmacol Toxicol 58:182-186.
19. Tornros J, Laurell H (1990) Acute and carry-over effects of brotizolam compared to nitrazepam and placebo in monotonoussimulateddriving. PharmacolToxicol 67:77-80.
20. Vermeeren A, Riedel WJ, Van Boxtel MPJ, et al. (2002) Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of ethanol. Sleep 25:224-231
21. Barbone F, McMahon AD, Davey PG, Morris AD, Reid IC, McDevitt DG, MacDonald TM (1998) Association of road-traffic accidents with benzodiazepine use. The Lancet 352:1331-1336
22. Verster JC, Volkerts ER, Schreuder AHCML, et al. (2002) Residual effects of middle-ofthe-night administration of zaleplon and Zolpidem on driving ability, memory functions, and psychomotor performance. J Clin Psychopharmacol 22:576-583
23. Verster JC, Volkerts ER, Johnson W, Liddicoat L (2007) Zolpidem and traffic safety - the importance of treatment compliance. Current Drug Safety 2:220-226
24. Verster JC, Veldhuijzen DS, Volkerts ER (2004) Residual effects of sleep medication on driving ability. Sleep Medicine Reviews 8:309-325
25. Hemmelgarn B, Suissa S, Huang A, Boivin J-F, Pinard G (1997) Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 278:27-31
26. Ray WA, Fought RL, Decker MD (1992) Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. Am J Epidemiol 136:873-883
27. Neutel CI (1995) Risk of traffic accident injury after a prescription for a benzodiazepine. Ann Epidemiol 5:239-244